Ipek Isık Gonul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ipek Isık Gonul has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Betül Öğüt
Department of Pathology, Faculty of Medicine, Gazi University, Ankara, Turkiye
3 shared publications - Asli Cakir
Department of Pathology, İstanbul Medipol University, İstanbul, Turkey
2 shared publications Turgut Alkibay
2 shared publications- Özant Helvacı
Department of Nephrology, Faculty of Medicine, Gazi University, 06560 Ankara, Turkey
2 shared publications - Arzu Bakirtas
Department of Pediatric Allergy, Gazi University Faculty of Medicine, Ankara, Türkiye
1 shared publication Asl Çakr
1 shared publication
Latest Publications
- Open Access
- 6 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8682
Glomerular C4d Deposition and Persistent Proteinuria in IgA Nephropathy: A Longitudinal Cohort Study
Background: Complement activation contributes to the pathogenesis of immunoglobulin A nephropathy (IgAN), and glomerular C4d deposition is a tissue marker of lectin and classical pathway activation. Whether C4d deposition and its intraglomerular localization are associated with longitudinal kidney outcomes independently of baseline disease severity remains uncertain. Methods: This retrospective single-center cohort included 77 adults with biopsy-proven primary IgAN. C4d was assessed immunohistochemically and considered positive when present in >25% of non-sclerotic glomeruli; positive biopsies were classified according to mesangial or glomerular capillary localization, and staining confined to sclerotic segments or Bowman’s capsule was not considered positive. eGFR and proteinuria measured from baseline to 48 months were analyzed using linear mixed-effects models, with adjustment for baseline proteinuria, Oxford S1, and corticosteroid treatment. Kidney failure, defined as sustained eGFR < 15 mL/min/1.73 m2, maintenance dialysis, or kidney transplantation, was analyzed using Kaplan–Meier and Cox regression analyses. Results: Glomerular C4d deposition was present in 32 patients (41.6%), with mesangial and glomerular capillary deposition in 15 (19.5%) and 17 (22.1%), respectively. Baseline proteinuria, S1 frequency, and serum C3 and C4 levels did not differ significantly according to C4d status. Mesangial C4d deposition was associated with S1 lesions (80.0% vs. 51.6%; p = 0.046). C4d-positive patients had persistently higher proteinuria during follow-up (p = 0.002), and this association remained after adjustment (geometric mean ratio 1.67, 95% CI 1.07–2.61; p = 0.026). The eGFR trajectory did not differ according to C4d status (p = 0.808). Kidney failure occurred in 11 patients (14.3%) and was not associated with C4d positivity after adjustment for baseline eGFR (HR 0.96, 95% CI 0.23–4.09). Neither localization was independently associated with longitudinal outcomes. Conclusions: In IgAN, glomerular C4d deposition was associated with persistently higher proteinuria after adjustment for baseline proteinuria, Oxford S1 status, and corticosteroid treatment, but was not significantly associated with longitudinal eGFR changes or kidney failure. The clinical relevance of C4d localization requires further evaluation in larger cohorts with longer follow-up.
- 6 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8682
Open AccessGlomerular C4d Deposition and Persistent Proteinuria in IgA Nephropathy: A Longitudinal Cohort Study
Background: Complement activation contributes to the pathogenesis of immunoglobulin A nephropathy (IgAN), and glomerular C4d deposition is a tissue marker of lectin and classical pathway activation. Whether C4d deposition and its intraglomerular localization are associated with longitudinal kidney outcomes independently of baseline disease severity remains uncertain. Methods: This retrospective single-center cohort included 77 adults with biopsy-proven primary IgAN. C4d was assessed immunohistochemically and considered positive when present in >25% of non-sclerotic glomeruli; positive biopsies were classified according to mesangial or glomerular capillary localization, and staining confined to sclerotic segments or Bowman’s capsule was not considered positive. eGFR and proteinuria measured from baseline to 48 months were analyzed using linear mixed-effects models, with adjustment for baseline proteinuria, Oxford S1, and corticosteroid treatment. Kidney failure, defined as sustained eGFR < 15 mL/min/1.73 m2, maintenance dialysis, or kidney transplantation, was analyzed using Kaplan–Meier and Cox regression analyses. Results: Glomerular C4d deposition was present in 32 patients (41.6%), with mesangial and glomerular capillary deposition in 15 (19.5%) and 17 (22.1%), respectively. Baseline proteinuria, S1 frequency, and serum C3 and C4 levels did not differ significantly according to C4d status. Mesangial C4d deposition was associated with S1 lesions (80.0% vs. 51.6%; p = 0.046). C4d-positive patients had persistently higher proteinuria during follow-up (p = 0.002), and this association remained after adjustment (geometric mean ratio 1.67, 95% CI 1.07–2.61; p = 0.026). The eGFR trajectory did not differ according to C4d status (p = 0.808). Kidney failure occurred in 11 patients (14.3%) and was not associated with C4d positivity after adjustment for baseline eGFR (HR 0.96, 95% CI 0.23–4.09). Neither localization was independently associated with longitudinal outcomes. Conclusions: In IgAN, glomerular C4d deposition was associated with persistently higher proteinuria after adjustment for baseline proteinuria, Oxford S1 status, and corticosteroid treatment, but was not significantly associated with longitudinal eGFR changes or kidney failure. The clinical relevance of C4d localization requires further evaluation in larger cohorts with longer follow-up.
- 1 December 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 105 (6) , 1782-1785
Case Report: A Human Case of Onchocerca lupi Mimicking Nodular Scleritis
: We report a case of human ocular onchocerciasis by zoonotic Onchocerca lupi presenting as nodular scleritis. Molecular analyses were used to confirm diagnosis at species level. In addition to few existing reports of human infection by O. lupi in Turkey, this case further suggests that the pathogen might be more common than previously reported, thus requiring further attention and investigations.
- 1 December 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 105 (6) , 1782-1785
Case Report: A Human Case of Onchocerca lupi Mimicking Nodular Scleritis
: We report a case of human ocular onchocerciasis by zoonotic Onchocerca lupi presenting as nodular scleritis. Molecular analyses were used to confirm diagnosis at species level. In addition to few existing reports of human infection by O. lupi in Turkey, this case further suggests that the pathogen might be more common than previously reported, thus requiring further attention and investigations.
- 11 June 2019
- Published by Springer Nature in International Urology and Nephrology
- Vol. 51 (8) , 1387-1394
Is it possible to prevent contrast-induced nephropathy with dexpanthenol?
Contrast-induced nephropathy (CIN) is one of the side effects of diagnostic procedures. Oxidative stress plays an important role in CIN’s pathophysiology. Dexpanthenol (Dexp) is a substance with antioxidant efficacy. We investigated the likely protective effects of dexpanthenol for CIN.
- 11 June 2019
- Published by Springer Nature in International Urology and Nephrology
- Vol. 51 (8) , 1387-1394
Is it possible to prevent contrast-induced nephropathy with dexpanthenol?
Contrast-induced nephropathy (CIN) is one of the side effects of diagnostic procedures. Oxidative stress plays an important role in CIN’s pathophysiology. Dexpanthenol (Dexp) is a substance with antioxidant efficacy. We investigated the likely protective effects of dexpanthenol for CIN.
- 1 March 2017
- Published by Elsevier in Pathology - Research and Practice
- Vol. 213 (3) , 227-234
GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas
- 1 March 2017
- Published by Elsevier in Pathology - Research and Practice
- Vol. 213 (3) , 227-234
GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas
- Open Access
- 16 June 2014
- Published by MDPI AG in Pediatric Reports
- Vol. 6 (2) , 31-32
Two Cases of Esophageal Eosinophilia: Eosinophilic Esophagitis or Gastro-Esophageal Reflux Disease?
Eosinophilic esophagitis (EoE) and gastro-esophageal reflux disease are among the major causes of isolated esophageal eosinophilia. Isolated esophageal eosinophilia meeting criteria for EoE may respond to proton pump inhibitor (PPI) treatment. This entity is termed proton pumps inhibitor responsive esophageal eosinophilia (PPI-REE). Gastro-esophageal reflux is thought to comprise a subgroup of patients with PPI-REE. According to the latest guidelines, PPI responsiveness distinguishes people with PPI-REE from patients having EoE (non-responders). In this report, two unusual cases with findings belonging to both EoE and PPI-REE are discussed with known and unknown facts.
- 16 June 2014
- Published by MDPI AG in Pediatric Reports
- Vol. 6 (2) , 31-32
Open AccessTwo Cases of Esophageal Eosinophilia: Eosinophilic Esophagitis or Gastro-Esophageal Reflux Disease?
Eosinophilic esophagitis (EoE) and gastro-esophageal reflux disease are among the major causes of isolated esophageal eosinophilia. Isolated esophageal eosinophilia meeting criteria for EoE may respond to proton pump inhibitor (PPI) treatment. This entity is termed proton pumps inhibitor responsive esophageal eosinophilia (PPI-REE). Gastro-esophageal reflux is thought to comprise a subgroup of patients with PPI-REE. According to the latest guidelines, PPI responsiveness distinguishes people with PPI-REE from patients having EoE (non-responders). In this report, two unusual cases with findings belonging to both EoE and PPI-REE are discussed with known and unknown facts.
- Open Access
- 20 October 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 145
A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas
Breast carcinomas can be classified into five subtypes based on gene expression profiling or immunohistochemical characteristics. Among these subtypes, basal-like breast carcinomas (BLBCs) are one of the most studied group, due to their poor prognosis. The aim of this study was to investigate the prevalance, morphological and immunohistochemical features of BLBCs, in Turkish population.
- 20 October 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 145
Open AccessA comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas
Breast carcinomas can be classified into five subtypes based on gene expression profiling or immunohistochemical characteristics. Among these subtypes, basal-like breast carcinomas (BLBCs) are one of the most studied group, due to their poor prognosis. The aim of this study was to investigate the prevalance, morphological and immunohistochemical features of BLBCs, in Turkish population.
- 1 July 2009
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 102 (7) , 754-757
A Case of Tubulocystic Carcinoma Simultaneously Occurring with Clear Cell Type Renal Cell Carcinoma and Micropapillary Urothelial Carcinoma of Bladder
The coexistence of multiple and synchronous primary neoplasms in the genitourinary system has rarely been described in the literature. To our knowledge, this is the first report of a very rare tumor, a “tubulocystic carcinoma,” simultaneously occurring with micropapillary urothelial carcinoma in the bladder and clear cell type renal cell carcinoma in the same kidney....
- 1 July 2009
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 102 (7) , 754-757
A Case of Tubulocystic Carcinoma Simultaneously Occurring with Clear Cell Type Renal Cell Carcinoma and Micropapillary Urothelial Carcinoma of Bladder
The coexistence of multiple and synchronous primary neoplasms in the genitourinary system has rarely been described in the literature. To our knowledge, this is the first report of a very rare tumor, a “tubulocystic carcinoma,” simultaneously occurring with micropapillary urothelial carcinoma in the bladder and clear cell type renal cell carcinoma in the same kidney....
- 1 October 2008
- Published by Elsevier in Pathology - Research and Practice
- Vol. 204 (10) , 707-717
Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder
- 1 October 2008
- Published by Elsevier in Pathology - Research and Practice
- Vol. 204 (10) , 707-717
Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder
- 1 May 2007
- Published by S. Karger AG in Urologia Internationalis
- Vol. 78 (4) , 338-344
Comparison of 1998 WHO/ISUP and 1973 WHO Classifications for Interobserver Variability in Grading of Papillary Urothelial Neoplasms of the Bladder
Aim: Our aim was to compare the interobserver variability between the 1998 WHO/ISUP and 1973 WHO classifications. Methods: 258 consecutive papillary urothelial carcinomas were reviewed by two pathologists and assigned a tumor grade according to the 1973 WHO and 1998 WHO/ISUP without the knowledge of primary diagnosis and clinical follow-up. All cases were also histologically staged by the two pathologists separately as follows: pTa (noninvasive), pT1 (lamina propria invasion only), pT2 (muscularis propria invasion). Findings of both pathologists and degree of agreement were compared statistically by using Pearson’s χ2 test and ĸ statistics respectively. A ĸ value of 0.21–0.40 is accepted as fair, 0.41–0.60 moderate and 0.61–0.80 substantial agreement. Results: Regardless of the pathologist, tumor grades of two classifications correlated to each other and the pathological stage (p < 0.05). Overall degree of agreement between pathologists was higher in the 1998 WHO/ISUP (ĸ 0.59) than the 1973 WHO (ĸ 0.41), but both were still moderate. Papillary urothelial neoplasia with low malignant potential was the group of 1998 WHO/ISUP that showed the lowest degree of agreement and if excluded, interobserver variability of the 1998 WHO/ISUP decreased significantly (ĸ 0.84). Conclusion: The diagnosis of papillary urothelial neoplasia with low malignant potential and the criteria that differentiates it from low-grade carcinomas needs improvement in order to compare the different studies and therapies and to provide more accurate information for management.
- 1 May 2007
- Published by S. Karger AG in Urologia Internationalis
- Vol. 78 (4) , 338-344
Comparison of 1998 WHO/ISUP and 1973 WHO Classifications for Interobserver Variability in Grading of Papillary Urothelial Neoplasms of the Bladder
Aim: Our aim was to compare the interobserver variability between the 1998 WHO/ISUP and 1973 WHO classifications. Methods: 258 consecutive papillary urothelial carcinomas were reviewed by two pathologists and assigned a tumor grade according to the 1973 WHO and 1998 WHO/ISUP without the knowledge of primary diagnosis and clinical follow-up. All cases were also histologically staged by the two pathologists separately as follows: pTa (noninvasive), pT1 (lamina propria invasion only), pT2 (muscularis propria invasion). Findings of both pathologists and degree of agreement were compared statistically by using Pearson’s χ2 test and ĸ statistics respectively. A ĸ value of 0.21–0.40 is accepted as fair, 0.41–0.60 moderate and 0.61–0.80 substantial agreement. Results: Regardless of the pathologist, tumor grades of two classifications correlated to each other and the pathological stage (p < 0.05). Overall degree of agreement between pathologists was higher in the 1998 WHO/ISUP (ĸ 0.59) than the 1973 WHO (ĸ 0.41), but both were still moderate. Papillary urothelial neoplasia with low malignant potential was the group of 1998 WHO/ISUP that showed the lowest degree of agreement and if excluded, interobserver variability of the 1998 WHO/ISUP decreased significantly (ĸ 0.84). Conclusion: The diagnosis of papillary urothelial neoplasia with low malignant potential and the criteria that differentiates it from low-grade carcinomas needs improvement in order to compare the different studies and therapies and to provide more accurate information for management.